CATIE - Canada's source for HIV and hepatitis C information

Large U.S. study explores risk of cancers in people with HIV

HIV treatment has extended life expectancies and reduced the risk of many cancers. However, people with HIV still have a higher risk for some cancers than people without HIV. As people with HIV live longer, risk also increases for cancers seen more among older people.

Similar survival rates found in people who get dual organ transplants—regardless of HIV status

A U.S. study focused on heart and other organ transplants in people with and without HIV. Survival rates over one to two years were similar in people regardless of HIV status. Research is needed on long-term survival and the equitable distribution of organs.

Large study finds many benefits arise from curing hepatitis C virus

B.C. researchers reviewed health indicators of more than 22,000 people who had hepatitis C. Those treated and cured had a lower risk of kidney, heart, stroke and neurocognitive issues. The findings demonstrate the broader health benefits of hepatitis C treatment beyond the liver.

Healthcare provider strategies for engaging and re-engaging people living with HIV in healthcare

In a recent study, healthcare providers in British Columbia offered valuable insights into their strategies for engaging and re-engaging people living with HIV in care.

CATIE statement on the need for a spectrum of substance use services

This CATIE statement was developed to support service providers and policy-makers to make informed decisions about the spectrum of substance use services.

About CATIE

CATIE strengthens Canada’s response to HIV, hepatitis C and the toxic drug crisis by bridging research and practice. We connect healthcare and community-based service providers with the latest science, and promote good practices for prevention, testing, treatment and substance use health programs.

Vision, mission, values